Top 3 Health Care Stocks That May Crash In May
Top 3 Health Care Stocks That May Crash In May
As of May 24, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
截至2024年5月24日，醫療保健行業的三隻股票可能會向將動量視爲交易決策關鍵標準的投資者發出真正的警告。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro.
RSI是一個動量指標，它比較股票在價格上漲的日子裏的走強與價格下跌的日子的走強。與股票的價格走勢相比，它可以讓交易者更好地了解股票在短期內的表現。根據Benzinga Pro的數據，當相對強弱指數高於70時，資產通常被視爲超買。
Here's the latest list of major overbought players in this sector.
以下是該行業主要超買參與者的最新名單。
TransMedics Group, Inc. (NASDAQ:TMDX)
TransMedics Group, Inc.（納斯達克股票代碼：TMDX）
- On April 30, TransMedics posted upbeat quarterly results and raised its 2024 guidance. "We are pleased with our first quarter results as we simultaneously drove continued revenue growth, expanded our infrastructure, and achieved profitability," said Waleed Hassanein, MD, President and Chief Executive Officer. The company's stock gained around 55% over the past month and has a 52-week high of $142.30.
- RSI Value: 78.24
- TMDX Price Action: Shares of TransMedics rose 0.4% to close at $137.53 on Thursday.
- 4月30日，TransMedics公佈了樂觀的季度業績，並上調了2024年的預期。總裁兼首席執行官Waleed Hassanein表示：“我們對第一季度的業績感到滿意，因爲我們同時推動了收入的持續增長，擴大了基礎設施並實現了盈利。”該公司的股票在過去一個月中上漲了約55％，創下了52周高點142.30美元。
- RSI 值：78.24
- TMDX價格走勢：週四，TransMedics的股價上漲0.4％，收於137.53美元。
CareDx, Inc (NASDAQ:CDNA)
CaredX, Inc（納斯達克股票代碼：CDNA）
- On May 9, CareDX reported better-than-expected first-quarter financial results and issued FY24 revenue guidance above estimates. "We set a new baseline in our Testing Services business in the second half of 2023 and are back to delivering sequential growth. I am pleased with the team's strong performance across all businesses this quarter," said John W. Hanna, CareDx President and CEO. The company's stock gained around 98% over the past month and has a 52-week high of $16.54.
- RSI Value: 76.48
- CDNA Price Action: Shares of CareDx rose 1.7% to close at $15.83 on Thursday.
- 5月9日，CaredX公佈的第一季度財務業績好於預期，併發布了高於預期的24財年收入指導。“我們在2023年下半年爲我們的測試服務業務設定了新的基準，並將恢復連續增長。我對該團隊本季度所有業務的強勁表現感到滿意。” CareDx總裁兼首席執行官約翰·漢納說。該公司的股票在過去一個月中上漲了約98％，創下了52周高點16.54美元。
- RSI 值：76.48
- CDNA價格走勢：週四，CaredX股價上漲1.7％，收於15.83美元。
Heron Therapeutics, Inc. (NASDAQ:HRTX)
Heron Therapeutics, Inc.（納斯達克股票代碼：HRTX）
- On May 7, Heron Therapeutics reported better-than-expected first-quarter financial results and reaffirmed its FY24 revenue guidance. "We are extremely pleased with our ability to improve the financial efficiency of the business by growing revenues, improving margins, and reducing expenses. We made tremendous progress this quarter by promptly training CrossLink sales representatives and integrating them into our commercial execution, while also training our own commercial team on the newly expanded label for ZYNRELEF," said Craig Collard, Chief Executive Officer of Heron. The company's stock gained around 31% over the past month and has a 52-week high of $3.59.
- RSI Value: 71.77
- HRTX Price Action: Shares of Heron Therapeutics closed at $3.47 on Thursday.
- 5月7日，Heron Therapeutics公佈的第一季度財務業績好於預期，並重申了其24財年的收入指導。“我們對我們能夠通過增加收入、提高利潤率和減少開支來提高業務財務效率感到非常滿意。Heron首席執行官克雷格·科拉德說，我們在本季度取得了巨大進展，及時培訓了CrossLink銷售代表並將其納入我們的商業執行中，同時還對我們自己的商業團隊進行了ZYNRELEF新擴張的品牌培訓。該公司的股票在過去一個月中上漲了約31％，創下52周高點3.59美元。
- RSI 值：71.77
- HRTX價格走勢：Heron Therapeutics的股價週四收於3.47美元。
Read This Next: SLB, First Solar And 2 Other Stocks Insiders Are Selling
接下來閱讀這篇文章：SLB、First Solar和其他兩隻股票內部人士正在賣出
譯文內容由第三人軟體翻譯。